Risk of Serious Infection in Patients With Rheumatoid Arthritis Treated With Biologic Versus Nonbiologic Disease‐Modifying Antirheumatic Drugs

OBJECTIVE: The objective of this study is to examine the risk of serious infections (SIs) associated with biological disease‐modifying antirheumatic drugs (bDMARDs) compared with conventional synthetic disease‐modifying antirheumatic drugs (csDMARDs) in patients with rheumatoid arthritis (RA). METHO...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:ACR Open Rheumatol
Hoofdauteurs: Ozen, Gulsen, Pedro, Sofia, England, Bryant R., Mehta, Bella, Wolfe, Frederick, Michaud, Kaleb
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2019
Onderwerpen:
Original Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6858027/
https://ncbi.nlm.nih.gov/pubmed/31777822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr2.11064
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items